MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with N

Naratriptan

Naratriptan 2.5mg tablets

Use with caution

Stability notes for Naratriptan 2.5mg tablets

Store in airtight container.

Provenance

Compatibility information derived from Naramig 2.5mg tablets (GlaxoSmithKline UK Ltd).

Suppliers (13) of Naratriptan 2.5mg tablets
Naramig 2.5mg tablets (CST Pharma Ltd)
Naramig 2.5mg tablets (GlaxoSmithKline UK Ltd)
Naramig 2.5mg tablets (Sigma Pharmaceuticals Plc)
Naratriptan 2.5mg tablets (A A H Pharmaceuticals Ltd)
Naratriptan 2.5mg tablets (Alliance Healthcare (Distribution) Ltd)
Naratriptan 2.5mg tablets (Crescent Pharma Ltd)
Naratriptan 2.5mg tablets (CST Pharma Ltd)
Naratriptan 2.5mg tablets (Ennogen Healthcare International Ltd)
Naratriptan 2.5mg tablets (Healthcare Pharma Ltd)
Naratriptan 2.5mg tablets (Medihealth (Northern) Ltd)
Naratriptan 2.5mg tablets (Morningside Healthcare Ltd)
Naratriptan 2.5mg tablets (Sigma Pharmaceuticals Plc)
Naratriptan 2.5mg tablets (Teva UK Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.